LONGTERM NON-RANDOMIZED RESULTS WITH A WITH A NEW CONTINUOUS RANGE OF VISION PRESBYOPIA-CORRECTING INTRAOCULAR LENS

Published 2022 - 26th ESCRS Winter Meeting

Reference: P086 | Type: Abstracts | DOI: 10.82333/cm6q-g207

Authors: Nikica Gabrić* ¹ , Ivan Gabric ²

¹Head of clinic,Eye Clinic Svjetlost,ZAGREB,Croatia, ²Refractive surgery,Eye Clinic Svjetlost,ZAGREB,Croatia

Purpose

To evaluate the long-term clinical outcomes and patient satisfaction with a new model of presbyopia-correcting intraocular lens (IOL) - Johnson & Johnson Synergy (ZFR00V)

Setting

Eye Clinic Svjetlost, Zagreb, Croatia

Methods

This non-randomised case series enrolled 800 eyes of 400 patients undergoing phacoemulsification cataract surgery with bilateral implantation of the TECNIS Synergy IOL (Johnson & Johnson Vision). UCDVA, UCNVA, mesopic reading conditions and overall patient-reported visual performance were evaluated during a 12-month-follow up.

Results

A total of 96.8% of patients chieved binocular postoperative uncorrected distance (UDVA) and near visual acuity (UNVA) of 0.00 logMAR (20/20), respectively. Mean postoperative mesopic UNVA for both eyes was 0.12 ± 0.04 logMAR. Likewise, mean binocular UDVA and UNVA were 0.00 ± 0.05 and 0.05 ± 0.03 logMAR. Posterior capsular opacification was observed as disturbing in 9% of patients and NdYAG laser capsulotomy was performed. Residual refractive error above 0.50 SE was observed in 17 eyes and was treated wit laser vision correction. Average residual refractive error before enhancement was 0.25 ± 0.13 sphere and 0.63 ± 0.23 cylinder.

Conclusion

This new presbyopia correcting IOL provided full spectacle independence in 99% patients with a limited deterioration of contrast sensitivity and patient reported dysphotopsias. We perceived this as a satisfactory outcome by the patient if proper patient selection is performed.